Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer. Silva Medeiros M, Botelho de Carvalho LA, Alves M, Papoila A, et al. Int Urol Nephrol 2024 Mar 26. doi: 10.1007/s11255-024-03971.

Read + Share

Amedeo Smart

Independent Medical Education

Silva Medeiros M, Botelho de Carvalho LA, Alves M, Papoila A, et al. Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer. Int Urol Nephrol 2024 Mar 26. doi: 10.1007/s11255-024-03971.
PMID: 38530585